November 2024
1. TONG X, Deng Y, Cizmeci D, Fontana L, et al
   Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
   J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956.
   

   >> Share

   
   March 2024
2. AL-AHMAD A
   Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
   J Immunol. 2024;212:753.
   

   >> Share

   
   January 2024
3. PULLEN RH 3RD, Sassano E, Agrawal P, Escobar J, et al
   A Predictive Model of Vaccine Reactogenicity Using Data from an In Vitro Human Innate Immunity Assay System.
   J Immunol. 2024 Jan 26:ji2300185. doi: 10.4049/jimmunol.2300185.
   

   >> Share

   
   
4. AUNG A, Irvine DJ
   Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines.
   J Immunol. 2024;212:171-178.
   

   >> Share

   
   
5. SOBRAL MC, Mooney DJ
   Materials-Based Approaches for Cancer Vaccination.
   J Immunol. 2024;212:179-187.
   

   >> Share

   
   
6. ZHENG YY, Zhao L, Wei XF, Sun TZ, et al
   Vaccine Molecule Design Based on Phage Display and Computational Modeling against Rhabdovirus.
   J Immunol. 2024 Jan 10:ji2300447. doi: 10.4049/jimmunol.2300447.
   

   >> Share

   
   
7. HORTA AL, Gigley J, Boutet M, Lavau G, et al
   Memory-like NK Cells Are a Critical Component of Vaccine-Induced Immunity to Trypanosoma cruzi Infection.
   J Immunol. 2024 Jan 10:ji2300509. doi: 10.4049/jimmunol.2300509.
   

   >> Share

   
   December 2023
8. PEIL J, Vossen C, Bock F, Clahsen T, et al
   Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma.
   J Immunol. 2023 Dec 15:ji2300063. doi: 10.4049/jimmunol.2300063.
   

   >> Share

   
   November 2023
9. LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al
   Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
   J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343.
   

   >> Share

   
   
10. EVANS JP, Liu SL
    Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
    J Immunol. 2023;211:1459-1467.
    

    >> Share

    
    October 2023
11. KING HAD, Pokkali S, Kim D, Brammer D, et al
    Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques.
    J Immunol. 2023 Oct 20:ji2300424. doi: 10.4049/jimmunol.2300424.
    

    >> Share

    
    
12. JOHNSON AMF, Hager K, Alameh MG, Van P, et al
    The Regulation of Nucleic Acid Vaccine Responses by the Microbiome.
    J Immunol. 2023 Oct 18:ji2300196. doi: 10.4049/jimmunol.2300196.
    

    >> Share

    
    
13. CHEN T, Guo J, Yang M, Zhu X, et al
    Expression of Concern: Chemokine-Containing Exosomes Are Released From Heat-Stressed Tumor Cells via Lipid Raft-Dependent Pathway and Act as Efficient Tumor Vaccine.
    J Immunol. 2023;211:1250.
    

    >> Share

    
    
14. DIAZ FE, McGill JL
    Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.
    J Immunol. 2023;211:1180-1186.
    

    >> Share

    
    September 2023
15. DE ARAUJO ACVSC, de Queiroz NMGP, Marinho FV, Oliveira SC, et al
    Bacillus Calmette-Guerin-Trained Macrophages Elicit a Protective Inflammatory Response against the Pathogenic Bacteria Brucella abortus.
    J Immunol. 2023;211:791-803.
    

    >> Share

    
    August 2023
16. ZHANG R, Tang L, Wang Y, Li Q, et al
    alpha-d-Glucose-1,6-Biphosphate Induces Dendritic Cell Homing to Enhance the Antitumor Effect of Neoantigen Vaccines.
    J Immunol. 2023 Aug 9:ji2200687. doi: 10.4049/jimmunol.2200687.
    

    >> Share

    
    July 2023
17. YU H, Worrall LJ, Berger T, Petric M, et al
    Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.
    J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282.
    

    >> Share

    
    June 2023
18. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    

    >> Share

    
    
19. MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al
    Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    J Immunol. 2023;210:1925-1937.
    

    >> Share

    
    
20. ZHANG Y, Hardy LC, Kapita CM, Hall JA, et al
    Intestinal Helminth Infection Impairs Oral and Parenteral Vaccine Efficacy.
    J Immunol. 2023 Jun 5:ji2300084. doi: 10.4049/jimmunol.2300084.
    

    >> Share

    
    May 2023
21. VINCENT BG, File DM, McKinnon KP, Moore DT, et al
    Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
    J Immunol. 2023 May 19:ji2300077. doi: 10.4049/jimmunol.2300077.
    

    >> Share

    
    April 2023
22. WANG H, Clapp B, Hoffman C, Yang X, et al
    A Single Nasal Dose Vaccination with a Brucella abortus Mutant Potently Protects against Pulmonary Infection.
    J Immunol. 2023 Apr 10:ji2300071. doi: 10.4049/jimmunol.2300071.
    

    >> Share

    
    March 2023
23. ALAM MM, Gower T, Jiang M, Oppenheim JJ, et al
    A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice.
    J Immunol. 2023 Mar 22:ji2200371. doi: 10.4049/jimmunol.2200371.
    

    >> Share

    
    
24. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    

    >> Share

    
    
25. CROUSE B, Baehr C, Hicks D, Pravetoni M, et al
    IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in Mice.
    J Immunol. 2023 Mar 20:ji2200605. doi: 10.4049/jimmunol.2200605.
    

    >> Share

    
    
26. SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al
    Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
    J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297.
    

    >> Share

    
    February 2023
27. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    

    >> Share

    
    
28. SACKETT K, Brown P, Dutta K, Scully IL, et al
    Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine Immunogenicity.
    J Immunol. 2023 Feb 1:ji2100849. doi: 10.4049/jimmunol.2100849.
    

    >> Share

    
    January 2023
29. NG T, Flores-Malavet V, Mansoor MAM, Arvelo AC, et al
    Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza.
    J Immunol. 2023 Jan 16:ji2200393. doi: 10.4049/jimmunol.2200393.
    

    >> Share

    
    
30. GINGERICH AD, Royer F, McCormick AL, Scasny A, et al
    Synergistic Protection against Secondary Pneumococcal Infection by Human Monoclonal Antibodies Targeting Distinct Epitopes.
    J Immunol. 2023;210:50-60.
    

    >> Share

    
    December 2022
31. SINGH AK, Majumder S, Wang X, Song R, et al
    Lung Resident Memory T Cells Activated by Oral Vaccination Afford Comprehensive Protection against Pneumonic Yersinia pestis Infection.
    J Immunol. 2022 Dec 7:ji2200487. doi: 10.4049/jimmunol.2200487.
    

    >> Share

    
    
32. MISE-OMATA S, Ikeda M, Takeshita M, Uwamino Y, et al
    Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant.
    J Immunol. 2022;209:2104-2113.
    

    >> Share

    
    November 2022
33. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022;209:1832-1836.
    

    >> Share

    
    
34. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022;209:1892-1905.
    

    >> Share

    
    
35. LOBBY JL, Uddback I, Scharer CD, Mi T, et al
    Persistent Antigen Harbored by Alveolar Macrophages Enhances the Maintenance of Lung-Resident Memory CD8(+) T Cells.
    J Immunol. 2022;209:1778-1787.
    

    >> Share

    
    October 2022
36. MISE-OMATA S, Ikeda M, Takeshita M, Uwamino Y, et al
    Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant.
    J Immunol. 2022 Oct 14. pii: jimmunol.2200525. doi: 10.4049/jimmunol.2200525.
    

    >> Share

    
    
37. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8(+) T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022 Oct 5. pii: jimmunol.2200577. doi: 10.4049/jimmunol.2200577.
    

    >> Share

    
    September 2022
38. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022 Sep 28. pii: jimmunol.2200369. doi: 10.4049/jimmunol.2200369.
    

    >> Share

    
    July 2022
39. COHEN KW, Tian Y, Thayer C, Seese A, et al
    Th2-Biased Transcriptional Profile Predicts HIV Envelope-Specific Polyfunctional CD4(+) T Cells That Correlated with Reduced Risk of Infection in RV144 Trial.
    J Immunol. 2022 Jul 8. pii: jimmunol.2101211. doi: 10.4049/jimmunol.2101211.
    

    >> Share

    
    
40. VENKATASUBRAMANIAN S, Pryor R, Plumlee C, Cohen SB, et al
    TOLLIP Optimizes Dendritic Cell Maturation to Lipopolysaccharide and Mycobacterium tuberculosis.
    J Immunol. 2022 Jul 8. pii: jimmunol.2200030. doi: 10.4049/jimmunol.2200030.
    

    >> Share

    
    June 2022
41. CUSIMANO GM, Gary EN, Bell MR, Warner BM, et al
    Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1.
    J Immunol. 2022 Jun 24. pii: jimmunol.2200056. doi: 10.4049/jimmunol.2200056.
    

    >> Share

    
    
42. NAGASHIMA K, Dzimianski JV, Han J, Abbadi N, et al
    The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
    J Immunol. 2022 Jun 13. pii: jimmunol.2101171. doi: 10.4049/jimmunol.2101171.
    

    >> Share

    
    
43. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al
    Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
    J Immunol. 2022;208:2461-2465.
    

    >> Share

    
    
44. KRMESKA V, Aggio JB, Nylen S, Wowk PF, et al
    Cyclooxygenase-Derived Prostaglandin E2 Drives IL-1-Independent Mycobacterium bovis Bacille Calmette-Guerin-Triggered Skin Dendritic Cell Migration to Draining Lymph Node.
    J Immunol. 2022;208:2549-2557.
    

    >> Share

    
    May 2022
45. RICHERT L, Lelievre JD, Lacabaratz C, Hardel L, et al
    T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.
    J Immunol. 2022 May 25. pii: jimmunol.2101076. doi: 10.4049/jimmunol.2101076.
    

    >> Share

    
    April 2022
46. SOMIYA M
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2022;208:1833.
    

    >> Share

    
    
47. BANSAL S, Fleming T, Mohanakumar T
    Response to Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2022;208:1833-1834.
    

    >> Share

    
    March 2022
48. DHUME K, Finn CM, Devarajan P, Singh A, et al
    Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.
    J Immunol. 2022 Mar 25. pii: jimmunol.2100801. doi: 10.4049/jimmunol.2100801.
    

    >> Share

    
    
49. YUZEFPOLSKIY Y, Morawski P, Fahning M, Speake C, et al
    Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
    J Immunol. 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
    

    >> Share

    
    
50. ROBERTS LM, Wehrly TD, Leighton I, Hanley P, et al
    Circulating T Cells Are Not Sufficient for Protective Immunity against Virulent Francisella tularensis.
    J Immunol. 2022;208:1180-1188.
    

    >> Share

    
    February 2022
51. KOHN EM, Dos Santos Dias L, Dobson HE, He X, et al
    SLAMF1 Is Dispensable for Vaccine-Induced T Cell Development but Required for Resistance to Fungal Infection.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100819. doi: 10.4049/jimmunol.2100819.
    

    >> Share

    
    
52. QIN Y, Teng Q, Feng D, Pei Y, et al
    Development of a Nanoparticle Multiepitope DNA Vaccine against Virulent Infectious Bronchitis Virus Challenge.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100909. doi: 10.4049/jimmunol.2100909.
    

    >> Share

    
    
53. SHAH JA, Warr AJ, Graustein AD, Saha A, et al
    REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis Risk.
    J Immunol. 2022 Feb 25. pii: jimmunol.2100671. doi: 10.4049/jimmunol.2100671.
    

    >> Share

    
    
54. DWIVEDI V, Gautam S, Headley CA, Piergallini T, et al
    IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette-Guerin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice.
    J Immunol. 2022 Feb 18. pii: jimmunol.2100900. doi: 10.4049/jimmunol.2100900.
    

    >> Share

    
    
55. MEYER-ARNDT L, Schwarz T, Loyal L, Henze L, et al
    Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4(+) T Cells following BNT162b2 Vaccination in the Elderly.
    J Immunol. 2022 Feb 4. pii: jimmunol.2100990. doi: 10.4049/jimmunol.2100990.
    

    >> Share

    
    
56. NICOLI F, Cabral-Piccin MP, Papagno L, Gallerani E, et al
    Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8(+) T Cells in Elderly Humans.
    J Immunol. 2022;208:562-570.
    

    >> Share

    
    January 2022
57. KOMISSAROV AA, Dolzhikova IV, Efimov GA, Logunov DY, et al
    Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
    J Immunol. 2022 Jan 31. pii: jimmunol.2101052. doi: 10.4049/jimmunol.2101052.
    

    >> Share

    
    
58. TU MK, Chiang SH, Bender RA, Wong DTW, et al
    The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100919. doi: 10.4049/jimmunol.2100919.
    

    >> Share

    
    December 2021
59. JONG RM, Van Dis E, Berry SB, Nguyenla X, et al
    Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection.
    J Immunol. 2021 Dec 29. pii: jimmunol.2100029. doi: 10.4049/jimmunol.2100029.
    

    >> Share

    
    November 2021
60. HINKLE L, Liu Y, Meng C, Chen Z, et al
    The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.
    J Immunol. 2021 Nov 12. pii: jimmunol.2100719. doi: 10.4049/jimmunol.2100719.
    

    >> Share

    
    
61. JEEWANDARA C, Guruge D, Pushpakumara PD, Kamaladasa A, et al
    Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    J Immunol. 2021 Nov 8. pii: jimmunol.2100762. doi: 10.4049/jimmunol.2100762.
    

    >> Share

    
    October 2021
62. LEFEBVRE MN, Drewry LL, Pewe LL, Hancox LS, et al
    Cutting Edge: Subunit Booster Vaccination Confers Sterilizing Immunity against Liver-Stage Malaria in Mice Initially Primed with a Weight-Normalized Dose of Radiation-Attenuated Sporozoites.
    J Immunol. 2021 Oct 29. pii: jimmunol.2100818. doi: 10.4049/jimmunol.2100818.
    

    >> Share

    
    
63. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    

    >> Share

    
    
64. SPURRIER MA, Jennings-Gee JE, Daly CA, Haas KM, et al
    The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation.
    J Immunol. 2021;207:1978-1989.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share